Medicaid program integrity audits increasingly turn on two numbers on the claim: the days supply billed and the timing of the next refill. When those numbers do not match the prescription's actual dosing instructions, state Medicaid auditors treat the mismatch as overbilling, not a clerical slip, and where the state's audit policy allows it, extrapolate flagged claims across the full audit period. A single miscalculated days supply is a correction. A pattern of them, paired with refills billed ahead of schedule, produces a recoupment demand with real dollars behind it.

How Pharmacies Calculate and Document Days Supply

CMS's self-audit guidance for Medicaid billing reduces days supply to two steps: multiply doses per day by days of therapy to set the quantity, then reverse-verify by dividing the dispensed quantity by the doses per day. CMS's own worked example is the finding auditors look for: a prescription for 100 tablets over a stated 30-day supply, taken three times daily, actually requires adjusting the days supply to 33 at that quantity. Billed as written, the claim overstates the days supply or, held at 100 tablets, exceeds the plan's maximum allowable days supply. CMS is explicit that the pharmacist must adjust the quantity or the documented days supply, not submit the claim as written. The same risk reaches any use-as-directed sig, where CMS calls for documenting frequency of use and maximum daily dose.

Early Refill Edits Vary by State Medicaid Program

Every state runs a point-of-sale edit blocking a refill until a set percentage of the prior fill's days supply has elapsed, and the percentage is not uniform. CMS's most recent National Medicaid FFS Drug Utilization Review report, for federal fiscal year 2023, puts the non-controlled-drug threshold as low as 75 percent in some states and as high as 93 percent in others, so a refill timed to clear one state's edit can still trip a neighboring state's. Controlled-substance thresholds run higher, with several states at 90 percent or above and South Carolina's threshold reaching 100 percent, leaving no early-refill window without an override. An override entered without a documented basis becomes the audit finding, separate from whether the days supply itself was calculated correctly.

A days supply that does not match the prescription's own dosing instructions is the finding, not a footnote to it.

What Medicaid Program Integrity Treats as Overbilling

State Medicaid program integrity units do not need a confession to open a file. Every state documents a process for identifying potential fraud, waste, or abuse in a pharmacy's billing of controlled drugs, and CMS's FFY2023 DUR report shows referral to the state's Program Integrity Unit or Surveillance Utilization Review unit is the most common action that process triggers, ahead of denying the claim outright. A days supply miscalculation reads the same way a dollar-amount outlier does: it separates the claim submitted from the prescription written. Repeated early refills without a documented override, inflated days supply figures, and undocumented overrides are the patterns auditors describe as overbilling. For how a referral moves once a state's program integrity unit opens a file, see Health Law Alliance's overview of Medicaid pharmacy audits and state program integrity.

Documentation That Supports an Audit Response

The pharmacy's own records separate a defensible days supply from an overbilling finding. CMS calls for the sig code, the dispensed quantity, and the days supply on the claim to reconcile on their face, and for any override to carry its own documented basis: a vacation supply, a confirmed prior authorization, or a prescriber's documented confirmation of a dose that exceeds the drug's labeling. That contemporaneous note is the record an auditor looks for first. Without it, a pharmacy argues its calculation after the fact, against a claims record that already shows the mismatch. An audit appeal turns on this kind of documentation, not an explanation written after the recoupment notice arrives. Health Law Alliance's Medicaid audit defense practice helps pharmacies build that record before a state audit ever opens a file.

Why Early Legal Counsel Is Critical

It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a Medicaid audit notice or a program integrity request for days supply or refill documentation. Early legal intervention can protect the pharmacy's rights, help avoid inadvertent admissions in override notes or staff interviews, and preserve defenses on appeal. A finding that escalates from a civil recoupment into a False Claims Act referral or an OIG exclusion proceeding carries consequences well beyond the dollar amount on the initial audit letter.

How Health Law Alliance Can Help

Health Law Alliance represents pharmacies through Medicaid program integrity audits built on days supply and early refill findings, from the initial document request through recoupment appeal. Health Law Alliance has represented 2,500+ clients nationwide. When a days supply or early refill finding also puts a pharmacy's license in front of a state board, contact us today for a free consultation on state board of pharmacy defense.